Rocket Pharmaceuticals (RCKT) PT Lowered to $7 at Leerink Partners
Tweet
Share
E-mail
Get Alerts RCKT Hot Sheet
Price: $3.47 +3.89%
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar lowered the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $7.00 (from $9.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Boeing lands two U.S. defense contracts worth over $711M
- Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
